2.
The renowned Breast Cancer expert Dr. Tim Eisen and the editor-in-chief of the series, Dr. Pere Gascón, selected the most recently published information by ASCO on the advances in the management of Renal Cancer and they evaluate their impact on daily clinical practice. Recent information is offered on the cancer cell hypothesis, the prognostic value of intratumoral neutrophils, the emerging new molecular classification, the anti-angiogenic agents, the therapeutic approaches metastatic disease, etc.